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Abstract
Arylamine N-acetyltransferase (NAT) genes in humans and in rodents encode polymorphic
drug metabolizing enzymes. Human NAT1 (and the murine equivalent mouse Nat2) is found
early in embryonic development and is likely to have an endogenous role. We report the detailed
expression of the murine gene (Nat2) and encoded protein in mouse embryos, using a
transgenic mouse model bearing a lacZ transgene inserted into the coding region of mouse Nat2.
In mouse embryos, the transgene was expressed in sensory epithelia, epithelial placodes giving
rise to visceral sensory neurons, the developing pituitary gland, sympathetic chain and
urogenital ridge. In Nat2
/ mice, the presence and activity of Nat2 protein was detected in
these tissues and their adult counterparts. Altered expression of the human orthologue in breast
tumours, in which there is endocrine signalling, suggests that human NAT1 should be
considered as a potential biomarker for neuroendocrine tissues and tumours.
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Introduction
The arylamine N-acetyltransferases (NATs) are clinically important in terms of their
role in metabolism of medicinal and environmental arylamines (Sim et al. 2007).
These genes are also implicated in cancer of the breast (Adam et al. 2003), bladder,
colon and prostate (Hein 2002). In humans, and in rodent models, the NAT genes are
polymorphic, and in vitro assays of acetylation by NAT enzymes using arylamine
substrates have been used to define the acetylation status of individuals (Weber &
Hein 1985). NAT genes comprise polymorphic multigene families located at syntenic
positions on chromosome 8 in mouse and man (Boukouvala & Fakis 2005), with
mouse used widely to model human NAT (Hein et al. 1997, Sugamori et al. 2003).
Correspondence: Edith Sim, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford,
OX1 3QT, UK. Tel: 44 1865 271634. Fax: 44 1865 281853. E-mail: edith.sim@pharm.ox.ac.uk
ISSN 1354-750X print/ISSN 1366-5804 online # 2008 Informa UK Ltd.
DOI: 10.1080/13547500701673529
Biomarkers, February 2008; 13(1): 106118Human NAT2 was initially identified as a determinant of isoniazid metabolism and is
largely active in the liver and intestine, indicating a role primarily in xenobiotic
metabolism, as is the mouse Nat1 enzyme (Sim et al. 2007). On the basis of
C-terminus sequence identity, substrate specificity and expression profile (Kawamura
et al. 2005), human NAT1 is orthologous to mouse Nat2. Human NAT1 and mouse
Nat2 are expressed in a wide range of adult tissues and active during embryogenesis
(McQueen et al. 2003), reviewed in (Boukouvala & Fakis 2005). Although
endogenous roles relating to folate metabolism (Minchin 1995), acetyl coenzyme A
or lipid homeostasis (Richards et al. 2004) have been postulated, the exact nature of
the endogenous role for human NAT1 is still not proven. To further understand the
role of human NAT1 in endogenous metabolism, we used homologous recombination
in a mouse model to achieve functional deletion of Nat2 (orthologous to human
NAT1) in mice, by insertion of lacZ into the mouse Nat2-coding region (Cornish
et al. 2003). This generated a mouse Nat2-knockout model (Nat2
/) lacking Nat2-
directed N- and O-acetyltransferase activities (Cornish et al. 2003, Loehle et al.
2006). As with mice lacking both Nat1 and Nat2 genes (Sugamori et al. 2003, 2006)
Nat2
/ mice do not display an obvious phenotype, however, the Nat2 null allele has
a gender-specific effect, giving rise to a sexual bias in Nat2 allelic inheritance. In the
homozygous state, the Nat2 null allele gives rise to a male bias in the A/J strain
(Cornish et al. 2003).
Although widely described as ubiquitously expressed, mouse Nat2 expression is
non-uniform within a given tissue. Within the cerebellum, for example, Nat2 is
robustly expressed in the Purkinje cells (Stanley et al. 1998). The present study
uses detailed histochemical analysis and enzymatic evidence to provide a novel
link between sites of robust Nat2 expression through embryogenesis and on into
adulthood and identifies Nat2 as a biomarker of neuroendocrine development.
Methods
Nat2 transgenic mouse maintenance and breeding
All work involving animals was carried out according to the UK Animals (Scientific
Procedures) Act of 1986 under license from the UK Home Office.
The generation of a stable Nat2 knockout line of mice by targeted insertion of a
lacZ-containing cassette, has been described (Cornish et al. 2003). Essentially, a
TAG3/IRES/lacZ/loxP/neo/loxP reporter ablation cassette was inserted into the Bgl II
site in the mouse Nat2 coding region, an MCl-thymidine kinase dimer negative
selection cassette was appended, and the resulting construct used to generate a null
allele of mouse Nat2 by homologous recombination in 129/Ola ES cells. The Nat2
null allele was bred onto a C57Bl/6 background by backcrossing Nat2
/ males to
C57Bl/6 females (supplied by Harlan UK) over eleven generations. Nat2
/ and
Nat2
/ animals used for analysis were generated by mating Nat2
/ male and
Nat2
/ females derived from backcross matings. On weaning, ear biopsies were
taken for genotyping. DNA was isolated using Sigma GenElute mammalian genomic
DNA miniprep kit. Primers used for genotyping of the Nat2 null allele were Neo-T
(forward) and mNat2-910 (reverse) with mNat2-1 (forward) and mNat2-910
(reverse) used to detect the wild-type Nat2 allele essentially as described (Cornish
et al. 2003). MgCl2 was used at a final concentration of 2 mM; polymerase chain
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30 s, annealing at 568C 30 s, elongation at 728C 45 s, 35 cycles.
To obtain embryos, timed matings were established, with noon on the day of the
vaginal plug designated as e 0.5. Pregnant dams were killed by cervical dislocation.
Embryos and associated yolk sacs were dissected from the uterus into ice-cold 10 mM
potassium phosphate pH 7.5, 145 mM NaCl (phosphate-buffered saline) containing
4% paraformaldehyde. DNA for genotyping embryos was isolated from yolk sacs as
described above.
Preparation of protein samples for immunoblotting and acetylation assays
Tissues were dissected from adult animals immediately following cervical dislocation,
trimmed, washed briefly in phosphate-buffered saline and either snap frozen and
stored in liquid nitrogen or used for preparation of homogenates. Tissues were
homogenized in three volumes of buffer: 20 mM KCl, 10 mM potassium phosphate
buffer pH 7.5, 1.0 mM EDTA, 1.0 mM DTT, 0.5 mM Pefabloc protease inhibitor
(Pentapharm, Basel, Switzerland), using an Ultraturax T25 tissue homogenizer, or, in
the case of embryonic mouse tissues, using glass Dounce homogenizers. Samples were
prepared for Western blotting or acetylation activities, and protein concentrations
determined as described previously (Smelt et al. 2000). For each genotype and each
sex, tissues were dissected from 8-week-old mice. Tissue homogenates were assayed
for their ability to acetylate para-aminobenzoic acid (pABA) essentially as described
(Smelt et al. 2000) or were used for immunoblotting. An aliquot of liver homogenate
made from pooled tissues taken from six adult male C57Bl/6 Nat2
/ mice was
included in each acetylation assay as an internal standard (Smelt et al. 2000).
For immunoblotting, filters were probed for 1 h at 208C with rabbit polyclonal
antiserum 184 (used at 1:4000), raised against the C-terminal dodecapeptide of
human NAT1, (identical to that of mouse Nat2), and conjugated to bovine serum
albumin, as described (Cornish et al. 2003). The amounts of protein loaded into
each well was confirmed by stripping the nitrocellulose filters for 30 min at 508Ci n
100 mM 2-mercaptoethanol, 2% (w/v) SDS, 62.5 mM TrisHCl pH 6.7, followed by
two 10-min washes in Tris-buffered saline (300 mM NaCl, 50 mM Tris pH 7.6, 0.1%
Tween 20), and overnight incubation in 3% non-fat dried milk powder diluted in Tris-
buffered saline to block, before reprobing with b-actin polyclonal antibodies (A5060
Sigma-Aldrich, UK), at a dilution of 1:500. Bound antibody was visualized using the
ECL Plus luminescent detection system (Amersham plc, UK).
Whole-mount staining for b-galactosidase activity
Embryos were isolated as above then transferred to formaldehyde/gluteraldehyde
buffer (2% formaldehyde, 0.2% gluteraldehyde, 0.02% NonidetP-40, 0.01% sodium
desoxycholate in phosphate-buffered saline) at room temperature for 10 min. After
fixation, tissues were rinsed four times in phosphate-buffered saline, then stained in
the dark overnight at 378C in x-gal stain solution (5 mM K3Fe(CN)6,5m M
K4Fe(CN)6,1m gm l
1 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (x-gal),
2 mM MgCl2, 0.02% NP-40, 0.01% sodium desoxycholate in 0.1 M phosphate buffer
pH 7.3 and 20 mM TrisHCl pH 7.3). For tissues showing high endogenous b-
galactosidase activity (adrenal and mammary glands) 5-bromo-3-indolyl-b-D-galac-
topyranoside (bluo-gal; Sigma-Aldrich) was used as substrate in place of x-gal. Tissues
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previously described (Rentschler et al. 2001). To observe x-gal staining at a cellular
level, tissue was fixed, stained with x-gal as above, dehydrated in a graded series of
methanol, cleared with Histoclear (RA Lamb, UK) and paraffin-embedded. Sections
were cut at 10 mm thickness, mounted on superfrost slides (VWR, UK), heated to
608C for 1 h and stored at room temperature. Structures were identified from serial
sections.
Immunohistochemistry
Immunohistochemistry was used to visualize mouse Nat2 protein in 10 mm sections
of e 11.5 embryos. Slides were dewaxed for 15 min in Histoclear and rehydrated
through a graded alcohol series. Immunohistochemical staining was visualized using
fast red-conjugated alkaline phosphatase (Dako EnVision, Dako, UK), following the
manufacturer’s instructions. Endogenous alkaline phosphatase activity was inhibited
with a 15-min incubation in 20% acetic acid. Sections were probed for 4 h at 208C
with polyclonal anti-Nat2 antibody 184 as previously described (Stanley et al. 1998).
Adjacent sections were incubated with preimmune serum (at 1:400) as controls.
Monoclonal antibody 3A10, against neurofilament-associated antigen (Yamada et al.
1991) was used at a dilution of 1 in 10. After immunostaining, sections were
counterstained with haematoxylin, air-dried and oil mounted.
Results
Mouse Nat2 expression in the developing neuroendocrine system
The activity of the Nat2 promoter can be visualized in Nat2 null mice in which the
lacZ gene disrupts the Nat2 coding region. This is achieved by monitoring the activity
of b-galactosidase (the lacZ gene product) using a colorimetric assay.
Nat2 gene expression was visualized via the blue product generated by b-galacto-
sidase activity in Nat2
/ embryos, over embryonic days e 8.511.5 (Figure 1).
During the period of neural tube closure, at e 8.5, Nat2 expression was detectable in
the neural tube and in the neural crest cells migrating towards the developing heart
(Figure 1A). Later, at e 10.5 Nat2 expression was visible in the developing peripheral
nervous system and parts of the central nervous system, more specifically, in the
olfactory placodes, the otic vesicle, the epibranchial placodes and the floor of the fourth
ventricle (Figure 1B). Nat2 expression also extended laterally from the optic cup along
the ventral surface of the optic stalk and anteroposteriorly along the floor plate. At
e 11.5, in addition to continued expression in the developing peripheral and central
nervous system, Nat2 was expressed in the hypothalamicpituitaryadrenal axis, from
Rathke’s pouch, along the sympathetic chain to the developing urogenital ridge (Figure
1C, D), from which the adrenocortical cells originate (Schulte et al. 2007).
Nat2 protein localization in the developing neuroendocrine system and Nat2 enzyme activity
during embryogenesis
To establish whether Nat2 promoter use, as assayed by x-gal staining in Nat2
/
embryos, is an indicator of productive gene expression, giving rise to functionally
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/ tissues, we performed immunohistochemical
and biochemical analyses using Nat2-specific antibodies and Nat2-specific substrates.
Nat2 promoter use is indicated by blue stain (Figure 2A), which shows robust
expression in the developing sympathetic chain. The presence of immunoreactive
mouse Nat2 in the developing sympathetic chain was probed in Nat2
/ embryos by
immunohistochemistry using a Nat2-specific polyclonal antibody (Stanley et al. 1996)
(Figure 2B). To establish whether Nat2 is expressed within neuronal or glial lineages,
neurons were identified by immunohistochemistry, using a monoclonal antibody to
neurofilament, visualized by fast red-conjugated alkaline phosphatase (Figure 2C).
The lack of significant overlap of red (neurofilament) and blue (x-gal) staining, and
partitioning of the x-gal stain in neurofilament-negative cells indicates that within the
sympathetic chain, Nat2 is expressed in glial cells (Figure 2C). Indications of robust
Nat2 gene expression in the developing sympathetic ganglia assayed using blue x-gal
Figure 1. Mouse Nat2 expression in the developing neuroendocrine system. (A) X-gal stained whole-mount
e 8.5 embryos, with Nat2*null expression visualized by x-gal stain. Left panel: ventral view of Nat2
/
embryo; right hand panel: Nat2
/ sibling control for endogenous b-galactosidase activity. (B) Whole-
mount preparation showing sensory placodes in Nat2
/ embryos at e 10.5. Left panel: embryo made
transparent with benzyl alcohol/benzoylbenzoate, arrowheads indicate optic cup, olfactory epithelium and
epibranchial placode; right panels: ventral views of partially dissected whole-mount preparations showing
primitive mouth (stomatodeum), olfactory epithelia and optic stalk (arrowheads). (C) Whole-mount
preparation of e 11.5 embryo. Arrowheads indicate Rathke’s pouch, ﬂoor of the IVth ventricle, and
mesonephric ducts, arrow indicates developing nodose ganglion. (D) Sections of x-gal stained e 11.5
Nat2
/ embryos, haematoxylin counterstained, showing components of the neuroendocrine system;
Rathke’s pouch, the retina, vomeronasal organ, sympathetic ganglia and mesonephric tubules (arrowheads).
Scale bars: (A) 250 mm, (BD) 500 mm. OV, otic vesicle; OC, optic cup; Oe, olfactory epithelium; EP,
epibranchial placode; St, stomatodeum; OS, optic stalk; IV, fourth ventricle; RP, Rathke’s pouch; VNO,
vomeronasal organ; SG, sympathetic ganglion; Mn, mesonephric tubule. Colour available online.
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/ embryos were confirmed by the presence of Nat2 protein
in sections of Nat2
/ siblings. The presence of mouse Nat2 protein in whole
embryos at e 11.5 was further demonstrated by Western blot analysis, and N-
acetyltransferase catalytic activity assayed in vitro using the mouse Nat2-dependent
substrate pABA (Figure 2D). Homogenates of Nat2
/ embryos at e 11.5
N-acetylated pABA, demonstrating that Nat2 was enzymatically active at this stage.
pABA acetylation was almost undetectable in Nat2
/ embryos, confirming the
functional deletion in the Nat2 null mutant. Thus, in Nat2
/ embryos, Nat2 protein
was both present and enzymatically active in the developing neuroendocrine system
from early in organogenesis.
Nat2 expression and acetylation activity in adult tissues
Heart. Nat2 expression in hearts taken from adult mice was also associated with
autonomic innervation. Nat2 expression was not detected in the ventricular
myocardial cells, but was detected in glial cells interspersed with atrial myocardial
cells (Figure 3A, B). Nat2 expression was also evident in glial cells accompanying the
sympathetic nerve along the coronary sinus (Figure 3E, F). No x-gal staining was
observed in hearts isolated from Nat2
/ mice (Figure 3C, D, G, H) indicating the
lack of endogenous b-galactosidase activity and therefore the specificity of x-gal
staining in adult Nat2
/ tissue (Figure 3A, B, E, F). These observations
are compatible with the continued expression of Nat2 through the development of
the sympathetic nervous system into adulthood.
Adrenal gland. As components of adrenal gland function can be considered to form
part of the neuroendocrine system, we have analyzed Nat2 protein levels and Nat2
catalytic acetylation activity in adrenal glands of adult mice (Figure 4). Adult mouse
adrenal glands showed significant levels of pABA N-acetylating activity in both males
and females (Figure 4B). In adult Nat2
/ mice, functional deletion of the Nat2
gene was confirmed by lack of immunoreactive Nat2 protein (Figure 4A) and pABA
Figure 2. Nat2 protein distribution and enzymatic activity at embryonic day 11.5. (A) Nat2
/ embryo at e
11.5, x-gal stained and prepared as whole mount. Panels show x-gal stain in transverse sections at the level of
the heart (plane indicated on whole-mount preparation) in Nat2
/ and Nat2
/ siblings; blue x-gal
staining in the sympathetic ganglia of Nat2
/ embryos, viewed also under high magniﬁcation, indicates
Nat2 gene expression. (B) Whole-mount preparation of x-gal stained Nat2
/ sibling illustrating the low
level of endogenous b-galactosidase. Panels show transverse sections through a Nat2
/ embryo at the level
of the heart, as indicated on the whole-mount preparation. Sections were probed with mouse Nat2-speciﬁc
polyclonal antibody 184 (Ab184) (Stanley et al. 1998) or preimmune serum (Pre-imm) as indicated and
visualized using alkaline phosphatase (AP)-conjugated fast red. Red stain viewed also under high
magniﬁcation indicates the presence of Nat2 protein. SG, sympathetic ganglia; RCV, right cardinal vein;
Lb, lung bud. (C) Transverse section through a Nat2
/ embryo ﬁxed and stained with x-gal (blue) to
reveal Nat2 expression and subsequently treated with a monoclonal antibody to neuroﬁlament, visualized
with AP-conjugated fast red to distinguish neuronal (red) from glial cells. Centre and right panels are high
magniﬁcation views of the sympathetic chain on the left and right side of the embryo indicated with black
arrows (left panel). (D) Western blot of homogenates of e11.5 Nat2
/ and Nat2
/ embryos testing for
the presence of Nat2 protein in Nat2
/ and Nat2
/ embryos (n6 per genotype). In vitro acetylation
assays using Nat2-speciﬁc substrate para-aminobenzoic acid (pABA) and acetyl coenzymeA, assaying Nat2-
dependent acetylating activity in homogenates of e 11.5 Nat2
/ and Nat2
/ embryos (n6 per
genotype for each of two independent experiments). Tissues from Nat2
/ and Nat2
/ embryos show a
signiﬁcant difference in pABA-speciﬁc acetylation activity (p0.03). NT, neural tube; Nc, notochord;
DRG, dorsal root ganglion; SG, sympathetic ganglion; LCV, left cardinal vein; RCV, right cardinal vein.
Colour available online.
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Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis 113N-acetylating activity in vitro (Figure 4B). Nat2 gene expression was detected, by
histochemical staining via the lacZ marker gene in Nat2
/ mice, both in the
glucocorticoid-synthesizing zona fasciculata layer of the adrenal cortex as well as being
scattered throughout the medulla (Figure 4C; and control for endogenous b-
galactosidase activity, Figure 4D).
Oviduct. We investigated the expression of Nat2 in normal mouse oviduct (Figure 5), a
tissue responsive to neuroendocrine signalling. Use of the lacZ gene in Nat2
/ mice
to monitor Nat2 expression, showed high levels of Nat2 expression in the luminal
epithelium (Figure 5A, C). This pattern of staining was not detected in luminal cells
from Nat2
/ mice, which lack the bacterial b-galactosidase. The samples in Figure 5
were initially stained with bluo-gal, to monitor Nat2 expression via the lacZ gene in
tissues from Nat2
/ mice. Samples shown in Figure 5C and D were subsequently
probed with a polyclonal antibody raised against mouse Nat2 protein. Fast red stain in
these panels shows that Nat2 protein was present in the luminal epithelium of oviducts
from Nat2
/ mice, but absent from the luminal epithelium of oviducts from
Nat2
/ mice, which lack functional Nat2 protein.
Discussion
Using Nat2 knockout transgenic mice to model human NAT1, we have extended
previous studies mapping the mouse Nat2 expression pattern and acetylation activity
Figure 4. Nat2 expression and catalytic activity in adrenal glands. (A) Western blot of adrenal gland
homogenatesfrommaleandfemaleadultNat2
/ andNat2
/ miceprobedwithpolyclonalantibody184at
1:4000 to detect Nat2. (B) Nat2 N-acetylation activity assayed in vitro using mouse Nat2-speciﬁc substrate
para-aminobenzoic acid (pABA). Cytoplasmic homogenates from adrenal glands of adult male and female
Nat2
/ and Nat2
/ mice were assayed for their ability to N-acetylate pABA. pABA acetylation rates in
adrenal glands from Nat2
/ and Nat2
/ are signiﬁcantly different (p210
5, n9 per sex and per
genotype tested in three independent assays). Samples from males and from females do not show signiﬁcant
differences in acetylationrate.(CandD) Transversesectionsthroughbluo-galstainedadrenalglandsisolated
fromadultNat2
/ (C)andNat2
/ (D)femalemice.Ca,capsule;Zf,zonafasciculate.Scalebars:100mm.
Colour available online.
114 L. Wakefield et al.in developing embryos. We found that Nat2 was expressed in the sensory epithelia and
epibranchial placodes, which give rise to the sensory neurons innervating the heart
and digestive system (Kirby 1988), in the sympathetic chain and developing urogenital
system. Nat2 expression has previously been described in the developing heart
Figure 5. Nat2 expression in oviduct epithelia. Transverse sections throughbluo-galstainedoviducts of adult
femaleNat2
/ andNat2
/ mice,analyzedforNat2expressionandNat2protein;bluestainindicatesNat2
expression,detectable in Nat2
/ tissues (A andC), red stainindicatesNat2protein in Nat2
/ tissues (D).
(AandC)Sectionsthroughbluo-galstainedoviductisolatedfromNat2
/ mice.(BandD)Sectionsthrough
bluo-gal stained control Nat2
/ mice. (C and D) After x-gal staining, sectioning and dewaxing, sections
were probed with polyclonal anti-Nat2 antibody 184, visualized with alkaline phosphatase-conjugated fast
red, to conﬁrm the presence of Nat2 in Nat2
/ tissues. Scale bars: (A, B) 20 mm; (C, D) 100 mm. Colour
available online.
Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis 115(Stanley et al. 1998, Wakefield et al. 2005). In neonates, cells expressing high levels of
Nat2 occur in regions of the heart innervated by the peripheral nervous system
(Wakefield et al. 2005). The location of Nat2 expression in both the developing and
adult heart, and punctate staining pattern (Figure 3) corresponds to that of Sox10-
expressing glial cells accompanying the autonomic innervation of the heart (Montero
et al. 2002). In embryos, identification of cells differentiating along a neuronal
pathway, using an anti-neurofilament antibody, positively identifies the sympathetic
chain and suggests that Nat2 is expressed in glial cells, as previously described
(Stanley et al. 1998), further supporting a neuroendocrine expression pattern. Nat2
expression in the developing sympathetic nervous system, which is largely derived
from folate-sensitive neural crest cells is compatible with the proposed role of human
NAT1 in folate metabolism (Minchin 1995). As in humans, we found that mouse
adrenal glands showed substantial pABA N-acetylating activity. Within the adrenal
glands Nat2 expression was observed both in the neural crest-derived medulla and in
the cortex. Since the adrenal cortex plays a major role in steroid hormone and
glucocorticoid synthesis from cholesterol, Nat2 expression in this region is consistent
with a functional role in the adult and developing neuroendocrine system.
The presence of human NAT1 in luminal cells within the gut, lung (Barker et al.
2006), bladder and kidney epithelia (Stanley et al. 1997), clearly indicates that its
expression is widespread. In these epithelia, human NAT1 may have an endogenous
function, in addition to that of xenobiotic metabolism. We observed robust mouse
Nat2 expression and Nat2 protein in mouse oviduct epithelia, known to respond to
endogenous and xenobiotic estrogens and Nat2 expression and Nat2 activity has been
previously demonstrated in rodent prostate tissue, which is also oestrogen responsive.
Previous studies in mice indicate that although the deletion of the Nat2 gene is
compatible with normal development, and most offspring are aphenotypic, the Nat2
null allele gives rise to skewed sex ratios both on mixed (Cornish et al. 2003) and pure
genetic backgrounds (Wakefield et al. 2006). These results indicate a gender-
dependent phenotype, discernable at the population level. Such a phenotype could
arise if Nat2 gene mutations have opposing effects on male and female offspring,
influencing sex ratios in utero and/or embryonic survival. Sex steroids (both oestrogen
and testosterone) and corticosteroids are synthesized and have biological roles in both
sexes and changes in the balance of these steroids may influence offspring sex ratios.
The pattern of robust Nat2 expression and gender-dependent effect of the Nat2 null
mutation implicate Nat2 function in the sexual dimorphism of neuroendocrine
function.
A correlation between human NAT1 overexpression and oestrogen receptor status
in breast cancer tissues has been described (Adam et al. 2003) which implicates
human NAT1 in oestrogen-positive breast tumours and in relapse-free survival
prognosis (Bieche et al. 2004). Using Nat2
/ mice, we have been able to
demonstrate low levels of expression in mouse mammary gland (Figure 6), indicating
that in mice as in humans low levels of expression of mouse Nat2/human NAT1 genes
is associated with normal growth of mammary epithelia. Our findings, using mouse
Nat2 to model human NAT1 function, indicate a novel aspect to the pattern of
expression of mouse Nat2/human NAT1 during embryogenesis and will be important
in understanding the role of the human NAT1 as a potential biomarker in breast
cancer.
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